US Stock MarketDetailed Quotes

NMRA Neumora Therapeutics

Watchlist

11.530
-0.350-2.95%

Trading Jul 17 13:06 ET

1.84BMarket Cap-7233P/E (TTM)

Neumora Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-30.01%-42.96M

-42.11%-163.28M

-69.41%-51.44M

-85.43%-47.77M

-16.71%-31.02M

-2.66%-33.04M

-52.34%-114.9M

-3.45%-30.37M

-49.30%-25.76M

-95.92%-26.58M

Net income from continuing operations

-50.80%-53.72M

-80.23%-235.93M

-286.31%-108.73M

-80.71%-53.03M

-26.90%-38.54M

17.23%-35.63M

44.84%-130.9M

-4.36%-28.15M

83.52%-29.34M

-78.54%-30.37M

Operating gains losses

----

-988.68%-577K

---316K

---16K

32.32%-134K

Depreciation and amortization

0.00%158K

12.46%668K

12.93%166K

18.49%173K

11.04%171K

7.48%158K

10.41%594K

12.21%147K

-2.67%146K

23.20%154K

Other non cash items

-2.83%791K

338.98%67.38M

8,017.15%64.86M

-16.44%859K

181.46%850K

-93.84%814K

-90.29%15.35M

-0.50%799K

-99.34%1.03M

11.44%302K

Change In working capital

1,062.14%3.59M

-28.08%-8.9M

-153.27%-13.11M

-314.95%-1.19M

194.62%5.1M

107.62%309K

-623.00%-6.95M

-15.56%-5.18M

-75.38%555K

-20.97%1.73M

-Change in prepaid assets

-6.45%7.35M

-214.25%-11.4M

-293.18%-8.13M

-642.46%-6.89M

-3,219.12%-4.24M

1,121.85%7.86M

-60.53%-3.63M

8.98%-2.07M

-37.08%-928K

-24.02%136K

-Change in payables and accrued expense

56.16%-2.96M

305.96%5.91M

-203.85%-4.07M

207.69%6.57M

466.28%10.16M

37.03%-6.75M

-149.41%-2.87M

133.39%3.92M

-32.43%2.13M

-21.11%1.79M

-Change in other current assets

----

--0

----

137.48%1.37M

-72.46%-6.25M

-1,080.00%-49K

--0

-Change in other current liabilities

-0.12%-802K

-86.36%-3.4M

-16.90%-913K

-44.35%-869K

-310.00%-820K

-229.63%-801K

-117.12%-1.83M

-194.72%-781K

-159.48%-602K

2.44%-200K

Cash from discontinued investing activities

Operating cash flow

-30.01%-42.96M

-42.11%-163.28M

-69.41%-51.44M

-85.43%-47.77M

-16.71%-31.02M

-2.66%-33.04M

-52.34%-114.9M

-3.45%-30.37M

-49.30%-25.76M

-95.92%-26.58M

Investing cash flow

Cash flow from continuing investing activities

-5,424.85%-150M

138.32%64.39M

270.32%13.68M

42.66%23.82M

126.44%24.08M

103.29%2.82M

-20,464.63%-168.01M

-4,171.28%-8.03M

3,151.74%16.69M

-83,450.46%-91.07M

Net PPE purchase and sale

--0

77.10%-117K

-91.30%-44K

71.54%-37K

--0

79.55%-36K

37.45%-511K

87.77%-23K

76.23%-130K

-66.97%-182K

Net investment purchase and sale

-5,330.49%-149.23M

144.72%69.09M

328.69%18.31M

41.78%23.85M

126.49%24.08M

103.94%2.85M

---154.5M

---8.01M

--16.82M

---90.89M

Net other investing changes

---775K

64.69%-4.59M

----

---13M

--0

Cash from discontinued investing activities

Investing cash flow

-5,424.85%-150M

138.32%64.39M

270.32%13.68M

42.66%23.82M

126.44%24.08M

103.29%2.82M

-20,464.63%-168.01M

-4,171.28%-8.03M

3,151.74%16.69M

-83,450.46%-91.07M

Financing cash flow

Cash flow from continuing financing activities

1,726.73%1.85M

100.39%231.94M

-101.79%-481K

166.15%232.02M

-85.98%292K

128.77%101K

-60.57%115.74M

7,595.25%26.83M

-70.14%87.18M

225.47%2.08M

Net common stock issuance

----

--232.88M

---491K

----

--0

----

Net preferred stock issuance

----

--0

----

-61.46%112.22M

39,738.10%24.97M

----

Proceeds from stock option exercised by employees

1,562.16%1.85M

-33.13%2.86M

-49.85%830K

949.31%1.51M

-82.50%404K

-32.32%111K

70.23%4.27M

95.63%1.66M

-80.62%144K

260.63%2.31M

Net other financing activities

----

-411.29%-3.8M

-498.06%-820K

-1,262.86%-2.86M

50.22%-112K

98.06%-10K

34.79%-744K

--206K

---210K

---225K

Cash from discontinued financing activities

Financing cash flow

1,726.73%1.85M

100.39%231.94M

-101.79%-481K

166.15%232.02M

-85.98%292K

128.77%101K

-60.57%115.74M

7,595.25%26.83M

-70.14%87.18M

225.47%2.08M

Net cash flow

Beginning cash position

54.93%375.25M

-40.83%242.21M

62.94%413.5M

16.95%205.43M

-27.18%212.08M

-40.83%242.21M

113.10%409.37M

-42.23%253.77M

6.40%175.66M

63.50%291.23M

Current changes in cash

-534.44%-191.11M

179.59%133.05M

-230.76%-38.25M

166.39%208.07M

94.24%-6.65M

74.50%-30.12M

-176.94%-167.17M

61.33%-11.56M

-71.51%78.11M

-786.52%-115.57M

End cash Position

-13.18%184.14M

54.93%375.25M

62.94%413.5M

16.95%205.43M

-27.18%212.08M

-40.83%242.21M

-42.23%253.77M

6.40%175.66M

Free cash flow

-29.86%-42.96M

-41.58%-163.4M

-69.42%-51.49M

-84.64%-47.81M

-15.92%-31.02M

-2.21%-33.08M

-51.38%-115.41M

-2.87%-30.39M

-48.19%-25.89M

-95.26%-26.76M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-30.01%-42.96M	-42.11%-163.28M	-69.41%-51.44M	-85.43%-47.77M	-16.71%-31.02M	-2.66%-33.04M	-52.34%-114.9M	-3.45%-30.37M	-49.30%-25.76M	-95.92%-26.58M
Net income from continuing operations	-50.80%-53.72M	-80.23%-235.93M	-286.31%-108.73M	-80.71%-53.03M	-26.90%-38.54M	17.23%-35.63M	44.84%-130.9M	-4.36%-28.15M	83.52%-29.34M	-78.54%-30.37M
Operating gains losses	----	----	----	----	----	----	-988.68%-577K	---316K	---16K	32.32%-134K
Depreciation and amortization	0.00%158K	12.46%668K	12.93%166K	18.49%173K	11.04%171K	7.48%158K	10.41%594K	12.21%147K	-2.67%146K	23.20%154K
Other non cash items	-2.83%791K	338.98%67.38M	8,017.15%64.86M	-16.44%859K	181.46%850K	-93.84%814K	-90.29%15.35M	-0.50%799K	-99.34%1.03M	11.44%302K
Change In working capital	1,062.14%3.59M	-28.08%-8.9M	-153.27%-13.11M	-314.95%-1.19M	194.62%5.1M	107.62%309K	-623.00%-6.95M	-15.56%-5.18M	-75.38%555K	-20.97%1.73M
-Change in prepaid assets	-6.45%7.35M	-214.25%-11.4M	-293.18%-8.13M	-642.46%-6.89M	-3,219.12%-4.24M	1,121.85%7.86M	-60.53%-3.63M	8.98%-2.07M	-37.08%-928K	-24.02%136K
-Change in payables and accrued expense	56.16%-2.96M	305.96%5.91M	-203.85%-4.07M	207.69%6.57M	466.28%10.16M	37.03%-6.75M	-149.41%-2.87M	133.39%3.92M	-32.43%2.13M	-21.11%1.79M
-Change in other current assets	----	--0	--0	--0	----	----	137.48%1.37M	-72.46%-6.25M	-1,080.00%-49K	--0
-Change in other current liabilities	-0.12%-802K	-86.36%-3.4M	-16.90%-913K	-44.35%-869K	-310.00%-820K	-229.63%-801K	-117.12%-1.83M	-194.72%-781K	-159.48%-602K	2.44%-200K
Cash from discontinued investing activities
Operating cash flow	-30.01%-42.96M	-42.11%-163.28M	-69.41%-51.44M	-85.43%-47.77M	-16.71%-31.02M	-2.66%-33.04M	-52.34%-114.9M	-3.45%-30.37M	-49.30%-25.76M	-95.92%-26.58M
Investing cash flow
Cash flow from continuing investing activities	-5,424.85%-150M	138.32%64.39M	270.32%13.68M	42.66%23.82M	126.44%24.08M	103.29%2.82M	-20,464.63%-168.01M	-4,171.28%-8.03M	3,151.74%16.69M	-83,450.46%-91.07M
Net PPE purchase and sale	--0	77.10%-117K	-91.30%-44K	71.54%-37K	--0	79.55%-36K	37.45%-511K	87.77%-23K	76.23%-130K	-66.97%-182K
Net investment purchase and sale	-5,330.49%-149.23M	144.72%69.09M	328.69%18.31M	41.78%23.85M	126.49%24.08M	103.94%2.85M	---154.5M	---8.01M	--16.82M	---90.89M
Net other investing changes	---775K	64.69%-4.59M	----	----	----	----	---13M	--0	--0	--0
Cash from discontinued investing activities
Investing cash flow	-5,424.85%-150M	138.32%64.39M	270.32%13.68M	42.66%23.82M	126.44%24.08M	103.29%2.82M	-20,464.63%-168.01M	-4,171.28%-8.03M	3,151.74%16.69M	-83,450.46%-91.07M
Financing cash flow
Cash flow from continuing financing activities	1,726.73%1.85M	100.39%231.94M	-101.79%-481K	166.15%232.02M	-85.98%292K	128.77%101K	-60.57%115.74M	7,595.25%26.83M	-70.14%87.18M	225.47%2.08M
Net common stock issuance	----	--232.88M	---491K	----	----	----	--0	--0	----	----
Net preferred stock issuance	----	--0	--0	----	----	----	-61.46%112.22M	39,738.10%24.97M	----	----
Proceeds from stock option exercised by employees	1,562.16%1.85M	-33.13%2.86M	-49.85%830K	949.31%1.51M	-82.50%404K	-32.32%111K	70.23%4.27M	95.63%1.66M	-80.62%144K	260.63%2.31M
Net other financing activities	----	-411.29%-3.8M	-498.06%-820K	-1,262.86%-2.86M	50.22%-112K	98.06%-10K	34.79%-744K	--206K	---210K	---225K
Cash from discontinued financing activities
Financing cash flow	1,726.73%1.85M	100.39%231.94M	-101.79%-481K	166.15%232.02M	-85.98%292K	128.77%101K	-60.57%115.74M	7,595.25%26.83M	-70.14%87.18M	225.47%2.08M
Net cash flow
Beginning cash position	54.93%375.25M	-40.83%242.21M	62.94%413.5M	16.95%205.43M	-27.18%212.08M	-40.83%242.21M	113.10%409.37M	-42.23%253.77M	6.40%175.66M	63.50%291.23M
Current changes in cash	-534.44%-191.11M	179.59%133.05M	-230.76%-38.25M	166.39%208.07M	94.24%-6.65M	74.50%-30.12M	-176.94%-167.17M	61.33%-11.56M	-71.51%78.11M	-786.52%-115.57M
End cash Position	-13.18%184.14M	54.93%375.25M	54.93%375.25M	62.94%413.5M	16.95%205.43M	-27.18%212.08M	-40.83%242.21M	-40.83%242.21M	-42.23%253.77M	6.40%175.66M
Free cash flow	-29.86%-42.96M	-41.58%-163.4M	-69.42%-51.49M	-84.64%-47.81M	-15.92%-31.02M	-2.21%-33.08M	-51.38%-115.41M	-2.87%-30.39M	-48.19%-25.89M	-95.26%-26.76M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall